Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BICX NYSE:CCM OTCMKTS:PCHM NASDAQ:PIII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBICXBiocorrx$0.24$0.37$0.20▼$0.50$7.05M0.17446 shs1,900 shsCCMConcord Medical Services$4.74-3.4%$3.78$3.18▼$10.77$21.27M-1.0922,321 shs257,984 shsPCHMPharmChem$3.75$3.75$2.95▼$3.98$17.43M0.617,005 shsN/APIIIP3 Health Partners$2.89+1.4%$2.68$1.52▼$11.30$20.56M0.4818,537 shs7,395 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBICXBiocorrx0.00%-6.98%0.00%+33.33%+30.42%CCMConcord Medical Services0.00%+2.88%+3.15%+0.38%-40.63%PCHMPharmChem0.00%0.00%0.00%0.00%+25.15%PIIIP3 Health Partners0.00%+8.52%+14.01%+45.05%-66.70%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBICXBiocorrx$0.24$0.37$0.20▼$0.50$7.05M0.17446 shs1,900 shsCCMConcord Medical Services$4.74-3.4%$3.78$3.18▼$10.77$21.27M-1.0922,321 shs257,984 shsPCHMPharmChem$3.75$3.75$2.95▼$3.98$17.43M0.617,005 shsN/APIIIP3 Health Partners$2.89+1.4%$2.68$1.52▼$11.30$20.56M0.4818,537 shs7,395 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBICXBiocorrx0.00%-6.98%0.00%+33.33%+30.42%CCMConcord Medical Services0.00%+2.88%+3.15%+0.38%-40.63%PCHMPharmChem0.00%0.00%0.00%0.00%+25.15%PIIIP3 Health Partners0.00%+8.52%+14.01%+45.05%-66.70%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBICXBiocorrx 2.00HoldN/AN/ACCMConcord Medical Services 1.00SellN/AN/APCHMPharmChem 0.00N/AN/AN/APIIIP3 Health Partners 2.00Hold$3.5021.11% UpsideCurrent Analyst Ratings BreakdownLatest BICX, CCM, PIII, and PCHM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2026PIIIP3 Health Partners Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/2/2026PIIIP3 Health Partners TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$8.00 ➝ $3.003/27/2026PIIIP3 Health Partners Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$12.50 ➝ $4.00(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBICXBiocorrx$800K8.81N/AN/A($0.47) per share-0.52CCMConcord Medical Services$65.85M0.31$1.79 per share2.64$60.94 per share0.08PCHMPharmChem$6.09M2.86N/AN/AN/A∞PIIIP3 Health Partners$1.46B0.01N/AN/A($21.55) per share-0.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBICXBiocorrx-$3.44M-$0.19N/AN/AN/AN/AN/A-59.39%5/11/2026 (Estimated)CCMConcord Medical Services-$13.27MN/AN/AN/AN/AN/AN/AN/AN/APCHMPharmChem$1.38M$0.2415.63N/AN/A17.92%N/AN/A5/7/2026 (Estimated)PIIIP3 Health Partners-$147.95M-$45.20N/AN/AN/A-10.14%-302.33%-20.72%5/14/2026 (Estimated)Latest BICX, CCM, PIII, and PCHM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026PIIIP3 Health Partners-$3.5050N/AN/AN/A$398.15 millionN/A5/11/2026N/ABICXBiocorrx-$0.06N/AN/AN/A$0.22 millionN/A4/29/2026Q4 2025CCMConcord Medical ServicesN/A-$1.08N/A-$1.08N/AN/A3/31/2026Q4 2025BICXBiocorrx-$0.06$0.05+$0.11$0.05$0.22 million($0.15) million3/26/2026Q4 2025PIIIP3 Health Partners-$8.0633-$23.02-$14.9567-$23.02$357.65 million$384.81 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBICXBiocorrxN/AN/AN/AN/AN/ACCMConcord Medical ServicesN/AN/AN/AN/AN/APCHMPharmChem$0.8021.33%N/A333.33%N/APIIIP3 Health PartnersN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBICXBiocorrxN/A0.100.08CCMConcord Medical Services1.330.480.46PCHMPharmChemN/AN/AN/APIIIP3 Health PartnersN/A0.240.24Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBICXBiocorrxN/ACCMConcord Medical ServicesN/APCHMPharmChemN/APIIIP3 Health Partners7.75%Insider OwnershipCompanyInsider OwnershipBICXBiocorrx21.40%CCMConcord Medical Services46.50%PCHMPharmChem17.40%PIIIP3 Health Partners17.79%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBICXBiocorrx328.96 million22.76 millionNot OptionableCCMConcord Medical Services9704.34 million2.32 millionNot OptionablePCHMPharmChem1704.65 million3.84 millionNot OptionablePIIIP3 Health Partners5007.21 million5.93 millionNot OptionableBICX, CCM, PIII, and PCHM HeadlinesRecent News About These CompaniesP3 Health Partners (PIII) price target decreased by 12.50% to 3.57April 28, 2026 | msn.comP3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference CallApril 16, 2026 | businesswire.comP3 Health Partners Inc. (PIII) Q4 2025 Earnings Call TranscriptMarch 26, 2026 | seekingalpha.comP3 Health Partners Announces Fourth Quarter and Full Year 2025 ResultsMarch 26, 2026 | businesswire.comP3 Health Partners Inc (PIII) Q4 2025: Everything You Need To Know Ahead Of EarningsMarch 25, 2026 | finance.yahoo.comP3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference CallMarch 13, 2026 | businesswire.comP3 Health Partners (PIII) price target decreased by 19.23% to 10.71December 6, 2025 | msn.comP3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACODecember 2, 2025 | businesswire.comP3 Health Partners Faces Nasdaq Compliance ChallengeNovember 28, 2025 | tipranks.comP3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity ConferenceNovember 24, 2025 | newsfilecorp.comNLake Street Maintains P3 Health Partners (PIII) Buy RecommendationNovember 18, 2025 | msn.comP3 Health Partners price target lowered to $12.50 from $20 at Lake StreetNovember 18, 2025 | msn.comP3 Health Partners Inc. (NASDAQ:PIII) Q3 2025 Earnings Call TranscriptNovember 15, 2025 | insidermonkey.comP3 Health Partners Inc. (PIII) Q3 2025 Earnings Call TranscriptNovember 14, 2025 | seekingalpha.comP3 Health Partners raises FY25 revenue view to $1.40-$1.45B from $1.35B-$1.5BNovember 13, 2025 | msn.comP3 Health Partners Announces Third Quarter 2025 ResultsNovember 13, 2025 | businesswire.comP3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference CallOctober 21, 2025 | businesswire.comP3 Health Partners to Participate in the Jefferies Healthcare Services ConferenceSeptember 17, 2025 | businesswire.comP3 Health Partners Earnings Call: Challenges and ProgressSeptember 8, 2025 | theglobeandmail.comCatalyst Solutions Announces Successful Launch of P3 Implementation Across Four StatesAugust 25, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBICX, CCM, PIII, and PCHM Company DescriptionsBiocorrx OTCMKTS:BICX$0.24 0.00 (0.00%) As of 05/4/2026 09:30 AM EasternBioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.Concord Medical Services NYSE:CCM$4.74 -0.17 (-3.37%) Closing price 03:59 PM EasternExtended Trading$5.24 +0.51 (+10.77%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.PharmChem OTCMKTS:PCHM$3.75 0.00 (0.00%) As of 05/1/2026PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.P3 Health Partners NASDAQ:PIII$2.89 +0.04 (+1.40%) Closing price 04:00 PM EasternExtended Trading$2.92 +0.02 (+0.87%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom The Great Chip Divide: AI Chip War Pivots from Hype to Execution Atomic Dividends: Big Tech's New Energy Bet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
